Fluidigm Launch Customer Web Videos

Hits:1655   Date: 7/6/2011

Fluidigm has added a new genre - customer web videos (www.fluidigm.com/biomark-videos.html) to the wide array of topical information (publications, application notes, posters, newsletters, press releases) available from its website.

Eve Marquis, Marketing Manager of Fluidigm Europe commented "Online video creates a more personal interaction between Fluidigm and our target audience in Single Cell, Gene Expression, SNP Genotyping, Next Generation Sequencing and Copy Number Variation markets. The use of both visual effects and commentary from existing customers is a great way of effectively communicating the value of implementing Fluidigm technological solutions in your lab. In today's fast paced world, it is much more efficient for someone to click on a video link than it is for them to read a page of text. People want fast and easy information, and web video allows them to have that".

The first customer web video from Dr Paul Robson from the Genome Insitute of Singapore reports on how he and fellow scientists have generated significant single cell expression data crucial for a detailed molecular understanding of mammalian development from fertilization to embryo implantation, a process known as the preimplantation period. The knowledge gained has a direct impact on clinical applications in the areas of regenerative medicine and assisted reproduction.

A further customer web video from Professor Mylene Yao of Stanford University reports upon her group's pioneering work using Fluidigm IFC technology to undertake single embryo gene expression has allowed them to gain a better understanding of early embryo development.

Fluidigm (NASDAQ:FLDM) develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm's proprietary microfluidic systems consist of instruments and consumables, including chips and reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets three microfluidic systems including eight different commercial chips to leading pharmaceutical and biotechnology companies, academic institutions and Ag-Bio companies. For more information, please visit www.fluidigm.com.

* Fluidigm, the Fluidigm logo, BioMark, Access Array, Dynamic Array, Digital Array, FC1, Topaz, and NanoFlex are trademarks or registered trademarks of Fluidigm Corporation.

* Cautionary Note About Forward-Looking Statements:  This press release contains "forward-looking" statements within the meaning of federal securities laws. Forward-looking statements include, among others, statements concerning or implying the performance attributes of Fluidigm's products and their ability to contribute to the effectiveness or cost of research studies. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by these forward-looking statements. Fluidigm's business, revenues, and operating results are and will be subject to numerous risks and uncertainties, including (among others) risks relating to market acceptance of our products, the potential for quarterly variations in our operating results, our ability to successfully launch new products and applications, competition in our primary markets, variability in our sales cycle, our need to expand our sales, marketing, and distribution capabilities, costs associated with our planned sales and research and development activities, risks associated with international operations, and our ability to attract and retain technical support personnel. In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in Fluidigm's filings with the United States Securities and Exchange Commission, including risks and uncertainties identified in our registration statement on Form S-1 as declared effective on February 9, 2011.

European Headquarters

 

Fluidigm SARL
15 Avenue de Norvege
91140 Villebon sur Yvette
France

 

Technical Contact: Leila Smith

Media Contact: Dr Bill Bradbury

tel. +33-160-924240 (Technical) / +44-208-546-0869 (Media)

email leila.smith@fluidigm.com / info@primetek-solutions.com

 

Worldwide Headquarters

Fluidigm Corporation

7000 Shoreline Court

Suite 100, South San Francisco

CA 94080
USA

www.fluidigm.com